Ameriprise’s Chembio diagnostics, Inc. CEMI Stock Holding History

Ameriprise’s Portfolio CEMI Stock Details CEMI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-52,625	Closed	-$132K	–	4124
2021 Q3	$132K	Sell	52,625 -50,628	-49%	-$140K	﹤0.01%	3756
2021 Q2	$307K	Sell	103,253 -19,855	-16%	-$69.2K	﹤0.01%	3636
2021 Q1	$432K	Buy	123,108 +13,477	+12%	+$75K	﹤0.01%	3467
2020 Q4	$521K	Buy	109,631 +13,374	+14%	+$69.1K	﹤0.01%	3330
2020 Q3	$467K	Buy	96,257 +4,348	+5%	+$20.6K	﹤0.01%	3262
2020 Q2	$299K	Sell	91,909 -30,009	-25%	-$285K	﹤0.01%	3368
2020 Q1	$624K	Hold	121,918	–	–	﹤0.01%	3031
2019 Q4	$556K	Buy	121,918 +6,800	+6%	+$33.1K	﹤0.01%	3298
2019 Q3	$705K	Buy	115,118 +10,602	+10%	+$63.2K	﹤0.01%	3160
2019 Q2	$637K	Hold	104,516	–	–	﹤0.01%	3249
2019 Q1	$580K	Buy	104,516 +16,865	+19%	+$110K	﹤0.01%	3242
2018 Q4	$496K	Buy	+87,651	New	+$646K	﹤0.01%	3189

Other funds holding CEMI

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

SFI

Susquehanna Fundamental Investments Bala Cynwyd, Pennsylvania $5.32B AUM 30.24% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Penbrook Management New York $157M AUM 46.57% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

EGM

Engineers Gate Manager New York $7.71B AUM 24.88% 1-Year Est. Return

Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return

Ameriprise's CEMI Position: Q4 2021 in Review

Ameriprise sold out of Chembio diagnostics, Inc. (CEMI) in Q4 2021, closing a stake of 52,625 shares — an estimated $132K sold.

Ameriprise first reported a position in CEMI in Q4 2018 and held it in 12 quarters. The position peaked at $705K in Q3 2019. 43 funds tracked by Wall St. Rank hold CEMI as of Q4 2021.

Ameriprise reported no remaining Chembio diagnostics, Inc. position as of Q4 2021 after selling out during the quarter.
Ameriprise sold 52,625 Chembio diagnostics, Inc. shares in Q4 2021, an estimated $132K.
Ameriprise first reported a position in Chembio diagnostics, Inc. in Q4 2018 and held it in 12 quarters.
Ameriprise's Chembio diagnostics, Inc. position peaked at $705K in Q3 2019.
43 funds tracked by Wall St. Rank held Chembio diagnostics, Inc. as of Q4 2021.

Based on Ameriprise's 13F filing for Q4 2021, filed 14 Feb 2022.